NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Diabetes and Metabolism > Volunteers sought for testosterone diabetes study

Volunteers sought for testosterone diabetes study

22 April 2015 · Listed under Diabetes and Metabolism

Men with Type 2 diabetes are needed for a study looking at a new treatment to correct low testosterone levels.

Volunteers aged 18-60 would receive injections of a hormone which researchers from the Churchill Hospital in Oxford have found can boost the body’s production of testosterone.

Testosterone levels are often low in men with type 2 diabetes and this is linked to increased risk of cardiovascular problems.

Symptoms of low testosterone can include tiredness, decreased exercise capacity and decreased libido.

The hormone which controls the release of testosterone in the brain is called kisspeptin.

It was scientists in Hershey’s, the chocolate town in America who discovered the kisspeptin gene. They named their hormone ‘kisspeptin’ after their town’s most famous product – Hershey’s Chocolate Kisses.

Research has shown a man-made long-acting version of kisspeptin hormone can increase testosterone levels.

Now researchers want to carry out a further study to decide on the amount to give and how often to give it, either once or twice weekly. This is so the drug can be evaluated further in future, larger studies.

The research is supported by the NIHR Oxford Biomedical Research Centre (BRC), set up by the Government in 2007 to quickly apply research to NHS care.

Dr Jyothis George, principal investigator for the BRC’s translational research group, said: “We are using a long-acting form of the natural hormone called kisspeptin to stimulate the body’s own production of testosterone.

“Current testosterone treatments increase the blood levels of testosterone above normal, often with side effects. Our approach aims to avoids this”

Phil Bacon, 58, of Marston, Oxford, who has Type 2 diabetes, received the drug once a week for four weeks as part of the trial.

Mr Bacon, a scientist, said: “I would always say ‘yes, get involved’. This is the only way science evolves and develops. I think it is a citizen’s duty to test these things.”

Taking part involves having injections in the skin near your belly button using a small needle – similar to injections such as insulin. Injections will be given for four weeks once or twice per week.

Participants would need to attend the Churchill’s OCDEM Clinical Research Unit frequently, for about six weeks. Most visits will be short morning visits, with a few long visits.

On completion of the study participants will be paid £1,900 or £2,700 for those who attend some additional long visits. Travel expenses will also be reimbursed.

Apply to take part now by calling Jo Milton on 01865 857246 or emailing volunteers@dtu.ox.ac.uk.

← National award for project providing better care for women with diabetes during pregnancy
Blood pressure linked to diabetes in major new study →

News

  • Environmental impact of 57,000 multi-ingredient processed foods revealed for first time 9 August 2022
  • £1.2m award to improve diagnosis of emergency spinal condition 4 August 2022
  • Workshop helps public contributors become ‘citizen experts’ on equality and diversity in research 4 August 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre